AlTi Global Inc. cut its holdings in Oracle Corporation (NYSE:ORCL – Free Report) by 18.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 86,843 shares of the enterprise software provider’s stock after selling 19,675 shares during the quarter. AlTi Global Inc.’s holdings in Oracle were worth $19,088,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Cardinal Point Capital Management ULC grew its holdings in shares of Oracle by 13.9% in the second quarter. Cardinal Point Capital Management ULC now owns 67,185 shares of the enterprise software provider’s stock valued at $14,689,000 after purchasing an additional 8,218 shares in the last quarter. Carnegie Investment Counsel grew its holdings in shares of Oracle by 11.1% in the second quarter. Carnegie Investment Counsel now owns 39,109 shares of the enterprise software provider’s stock valued at $8,550,000 after purchasing an additional 3,908 shares in the last quarter. Moser Wealth Advisors LLC grew its holdings in shares of Oracle by 1,770.0% in the second quarter. Moser Wealth Advisors LLC now owns 187 shares of the enterprise software provider’s stock valued at $41,000 after purchasing an additional 177 shares in the last quarter. Warburton Capital Management LLC purchased a new position in shares of Oracle in the second quarter valued at $268,000. Finally, FSM Wealth Advisors LLC grew its holdings in shares of Oracle by 36.9% in the second quarter. FSM Wealth Advisors LLC now owns 11,246 shares of the enterprise software provider’s stock valued at $2,612,000 after purchasing an additional 3,033 shares in the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Oracle news, Director William G. Parrett sold 11,500 shares of the business’s stock in a transaction dated Friday, September 12th. The shares were sold at an average price of $306.00, for a total value of $3,519,000.00. Following the completion of the transaction, the director directly owned 17,764 shares in the company, valued at approximately $5,435,784. The trade was a 39.30% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Michael D. Sicilia sold 33,845 shares of the business’s stock in a transaction dated Tuesday, September 23rd. The stock was sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the transaction, the insider owned 132,656 shares of the company’s stock, valued at $42,603,800.96. This represents a 20.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 170,769 shares of company stock valued at $50,297,667 in the last three months. 40.90% of the stock is currently owned by insiders.
Oracle Stock Up 2.7%
Oracle (NYSE:ORCL – Get Free Report) last released its quarterly earnings data on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). Oracle had a return on equity of 72.93% and a net margin of 21.08%.The business had revenue of $14.93 billion during the quarter, compared to analysts’ expectations of $15.04 billion. During the same period last year, the company earned $1.39 earnings per share. The firm’s revenue was up 12.2% compared to the same quarter last year. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. As a group, research analysts anticipate that Oracle Corporation will post 5 EPS for the current fiscal year.
Oracle Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, October 23rd. Shareholders of record on Thursday, October 9th were issued a $0.50 dividend. The ex-dividend date was Thursday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 0.7%. Oracle’s payout ratio is currently 46.30%.
Wall Street Analysts Forecast Growth
Several research analysts have commented on the stock. Melius Research lifted their price objective on shares of Oracle from $270.00 to $370.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Piper Sandler lifted their price objective on shares of Oracle from $330.00 to $380.00 and gave the stock an “overweight” rating in a research note on Friday, October 17th. UBS Group lifted their price objective on shares of Oracle from $360.00 to $380.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. Jefferies Financial Group lifted their price objective on shares of Oracle from $360.00 to $400.00 and gave the stock a “buy” rating in a research note on Friday, October 17th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Oracle from $185.00 to $210.00 and gave the stock a “neutral” rating in a research note on Monday, September 8th. Three research analysts have rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating, nine have issued a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $323.69.
Read Our Latest Stock Analysis on Oracle
About Oracle
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Recommended Stories
- Five stocks we like better than Oracle
- Consumer Discretionary Stocks Explained
- UnitedHealth’s Moment of Truth: 3 Bullish Signals to Watch For
- EV Stocks and How to Profit from Them
- Warner Bros. Bidding War Potential: How High Could WBD Shares Go?
- Top Biotech Stocks: Exploring Innovation Opportunities
- Analysts Eye 30% Upside in Netflix After Q3 Earnings Crash
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL – Free Report).
Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.
